the world congress summit on specialty market access and channel optimization

To register, please visit www.worldcongress.com/specialty • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: [email protected]

�

S t r a t e g i e S t o i m p r o v e p a t i e n t S e r v i c e S a n d a d h e r e n c e t h r o u g h c o n t r a c t i n g a n d d a t a a n a l y t i c S

t h e W o r l d c o n g r e S S S u m m i t o n

Specialty Market acceSS and channel OptiMizatiOn

J u l y 2 8 - 2 9 , 2 0 1 4 • H y a T T a T T H E B E l l E v u E • P H i l a d E l P H i a , P a

c o n f e r e n c e c h a i r p e r S o n :

Michael J. Baldzicki, CRCM Executive Vice President, Industry Relations and Advocacy ARMAdA HeAltH CARe

t o p i c S i n c l u d e : align the sales team with the hub to optimize your specialty

pharmacy channel an outlook for 2015 and beyond for specialty drug costs and utilization —

pBm perspective Keys to getting usable, timely, and error-free data in compliance with

your contract understand adherence measurement by disease and specialty drug category anticipated impacts of biosimilars on the uS specialty market improve engagement and adherence by using mobile or web-based tools

and virtual health assistants in specialty pharmacies

f e a t u r e d S p e a K e r S i n c l u d e :

Strategic partner:

media partnerS:

organized By:

S a v e u p t o $ 2 0 0 W h e n y o u r e g i S t e r B y J u n e 1 3 , 2 0 1 4 !

Patient

Manufacturer

PBM

SPecialty PharMacy

Whole- Saler

Kelly Burgeson Executive

Director, Oncology Pricing, Access,

Reimbursement and Distribution

BoeHRingeR-ingelHeiM

Raolo Frear, Pharmd

General Manager oMedARx

Bill goodson Deputy Director,

Pricing, Reimbursement and Patient Assistance

BAyeR HeAltHCARe

Ryan e. Ruzziconi, Jd, CHC

Vice President, General Counsel

diPloMAt

Mark M. Stephan Regional Director,

Access and Reimbursement,

Mid Atlantic AlKeRMeS

Wesley Winn Vice President,

Commercial Operations,

Supply Chain and Market Access

HyPeRion tHeRAPeutiCS

Dear Colleague,

The biopharmaceutical manufacturer’s strategy for how the product gets to the patient has implications for all stakeholder groups. Advances in drug delivery systems, complicated treatment regimens, and industry consolidation have created more complex distribution channels. It is critical that the manufacturer partner with the right organizations that have the capabilities and infrastructure to meet their needs and affected patient populations. Ultimately the success of a new drug depends on how well the manufacturer takes various factors into consideration when devising their channel strategy.

The World Congress Summit on Specialty Market Access and Channel Optimization will offer delegates from pharma, specialty pharmacies, distributors, and PBMs the opportunity to engage in dialogue on ways to work together to effectively manage the distribution of existing products and new specialty pharmaceutical launches. Highlights include:

• A frame up of contractual, operational and regulatory issues associated with contracting and a reactor panel that will give feedback on ways to improve the manufacturer-specialty pharmacy contractual relationship

• Key benefits and challenges applying adherence metrics across specialty drug therapies

• Data needs — What constitutes a good set of usable data from a Specialty Pharmacy and FMV pricing

Armada Health Care, the nation’s largest specialty pharmacy group purchasing and channel management organization, is proud to be a Strategic Partner of the Summit in its inaugural year and work with World Congress to have the most pressing challenges in the specialty market addressed on the agenda.

I invite you to join me in Philadelphia on July 28-29 for the opportunity to meet and connect with peers who share common goals and are interested in optimizing outcomes through collaboration.

Sincerely,

Michael J. Baldzicki, CRCM Executive Vice President, Industry Relations and Advocacy ARMAdA HeAltH CARe Chairperson, World Congress Summit on Specialty Market Access and Channel Optimization

Summit oBJective: This conference offers industry professionals multiple perspectives on the changes, challenges, and opportunities arising within this rapidly growing marketplace, and what the best practices are for addressing them. By 2018, 7 of the 10 top selling drugs in the US are expected to be specialty pharmaceuticals. Now is the time for manufacturers to exert maximum control over the design of their distribution channels and develop the right business partners that will maximize the value propositions of their new launches.

Who Should attend: Senior level leaders from:

Pharmaceutical industry

• Specialty

• Trade

• Channel

• Patient Services

• Market Access

• Reimbursement

Specialty Pharmacies:

• Managed Care Relations

• Industry Relations

• Business Development

Health Plans and PBMs:

• Medical Officer/Director

• Pharmacy (Specialty/Services/ Benefit/Network)

ConsidEr a sPonsorsHiP PaCkagE • Present to Key Players in your target Market • take Advantage of 1-on-1 Sponsor/Attendee Meetings Facilitated on-Site

CAPtuRe A tRue Roi tHRougH SPonSoRSHiP oF tHe FolloWing:Agenda thought leadership • networking Cocktail Reception • Breakfast Symposia • luncheon • executive networking Breaks

To inquire about Sponsorship and Executive Networking Opportunities, Contact David Capobianco, Vice President, Business Development, World Congress • Call 781-939-2635 or email [email protected]


P.S. — Don’t forget about the team discount. Find out more about special group

package discounts by calling 800-767-9499 or emailing

[email protected].

Strategic partner:

d a y o n e – m o n d a y , J u l y 2 8 , 2 0 1 47:30 am – 8:30 am Workshop Registration and Morning Coffee

8:30 am – 11:45am p r e - S u m m i t W o r K S h o p

Align the Sales Team with Your Hub to Optimize Your Specialty Pharmacy Channel Strategy • Identify nimble hubs and reduce barriers for timely functioning to ensure the best outcomes in terms of prior authorizations, time to fill,

and medication persistence• Apply a marketing mix to successfully promote your hub to the channel — Physicians and consumers• Bridge the gap between data aggregation and analysis with proper hub design• Collect the right data to drive adherence and set up a lexicon of data elements for program consistency

There is a 15 minute coffee and networking break from 10:00 am – 10:15 am

Mark M. Stephan, Regional Director, Access and Reimbursement, Mid Atlantic, AlKeRMeS

Mr. Stephan has over twenty-five years of experience in pharmaceutical sales, pharmaceutical sales management, managed care, national account management, and business development. He has been directly involved with the launch, sale, access/reimbursement, and distribution of specialty injectable products since 1998. While currently with Alkermes, Mr. Stephan has spent time at The Upjohn Company (Pharmacia), MedImmune, and Intercell.

Frank F. dolan, National Sales Director, CoRCePt tHeRAPeutiCS, inC.

Frank Dolan is the Director of Sales at Corcept Therapeutics and is an 18-year veteran of the pharmaceutical industry. His experience extends across marketing, business development, operations, and commercial leadership. In addition to having launched seven products, four first-in-class, Mr. Dolan has been instrumental in eight expansions, restructures, and mergers. He developed the award winning patient adherence program Byetta By Your Side. His past employers include Bristol-Myers, Amylin Pharmaceuticals, Takeda, Kos Pharmaceuticals, and Parke-Davis.

11:45 am – 1:00 pm Lunch on Your Own / Main Summit Registration

d a y o n e – m o n d a y , J u l y 2 8 , 2 0 1 4 • m a i n S u m m i t a g e n d a1:00 pm – 1:15 pm Chairperson’s Welcome and Opening Remarks


1:15 pm – 2:00 pm Future Outlook for Specialty Drug Costs and Utilization for High Risk Populations

• A review of new and existing ways that payers and PBMs are managing specialty drugs under the medical and pharmacy benefit to include a discussion on:

- drug formulary development - site of care administration - split-fill programs to improve adherence• Initiatives in development for key therapeutic categories — Oncology, Hepatitis C, RA, and MS• Maximizing co-pay and patient assistance program effectiveness to increase patient access

Raulo Frear, Pharmd General Manager oMedARx

Bill goodson Deputy Director, Pricing, Reimbursement and Patient Assistance BAyeR HeAltHCARe


don’t Miss This upcoming Event!

Patient Solution ServiceS and Hub DeSign

B r i n g r e i m B u r s e m e n t s u p p o r t p r o g r a m s B e y o n d t h e p i l l a u g u S t 1 9 - 2 0 , 2 0 1 4 • P H i l a D e l P H i a , P a


d a y o n e – m o n d a y , J u l y 2 8 , 2 0 1 4 ( c o n t i n u e d )2:00 pm – 3:30 pm Understand the Contractual, Operational, and Regulatory Nuances of Specialty Pharmacy Contracting

Hear a frame up of cases that give the manufacturer and specialty pharmacy perspectives addressing key legal, regulatory, and business challenges when initiating or re-contracting a distribution network

Michael R. Hess Chair-Drug, Device and Life Sciences Industry Service Team, BAKeR, donelSon, BeARMAn, CAldWell & BeRKoWitz, PC Former Chief Counsel and Vice President, Strategic Development, ACCRedo HeAltH gRouP

ReACTOR PANel: Improve Manufacturer and Specialty Pharmacy Contractual Relationships for Rare Disease and Specialty DrugsNegotiate agreements that efficiently and effectively move new products through distribution channels. This session discusses:

• Identification of legitimate services • Changing metrics and patient outreach strategies for improved adherence• Reimbursement and interface with the hub• Multiple co-pay and coupon assistance programs• Rebate strategies and structuring incentives for growth• Fair market value analysis

Moderator:

Michael R. Hess Chair-Drug, Device and Life Sciences Industry Service Team, BAKeR, donelSon, BeARMAn, CAldWell & BeRKoWitz, PC Former Chief Counsel and Vice President, Strategic Development, ACCRedo HeAltH gRouP

Ryan e. Ruzziconi, Jd, CHC Vice President, General Counsel diPloMAt

Wesley Winn Vice President, Commercial Operations, Supply Chain and Market Access HyPeRion tHeRAPeutiCS

3:30 pm – 4:00 pm Networking and Refreshment Break

4:00 pm – 4:45 pm Understand the Complexities of Adherence Measurement by Disease and Specialty Drug Category

• Understand current and planned specialty pharmacy measure development activities, including strategies to address challenges • Describe the differences between Medication Possession Ratio (MPR) and Proportion of Days Covered (PDC) and how that impacts adherence

measurement in specialty patient populations • Discuss key benefits and challenges with applying adherence metrics across specialty drug therapies

Moderator:

lynn Pezzullo, RPh, CPeHR Director of Performance Measurement and Research PHARMACy QuAlity AlliAnCe, inC.

Richard Faris, Phd, MS, RPh Director, Health Outcomes and Pharmacoeconomics (HOPE) uCB

Kelly Pokuta, Pharmd Director, Specialty Pharmacy CAtAMARAn

To inquire about Sponsorship and Executive Networking Opportunities, Contact David Capobianco, Vice President, Business Development, World Congress

Call 781-939-2635 or email [email protected]


d a y o n e – m o n d a y , J u l y 2 8 , 2 0 1 4 ( c o n t i n u e d )4:45 pm – 5:30 pm Anticipated Impact of Biosimilars on the Specialty landscape

• An overview of the key regulatory unknowns associated with biosimilars in the US• Understand the various perspectives and how stakeholders from manufacturers to physicians to payers will impact biosimilar uptake in the US• Key lessons from biosimilars outside of the US and successes and the challenges• Discuss implications for the distribution strategy for branded products

Molly Burich Senior Manager, Government Affairs — Reimbursement and Policy otSuKA PHARMACeutiCAlS

5:30 pm – 6:30 pm Cocktail and Networking Reception

d a y t W o – t u e S d a y , J u l y 2 9 , 2 0 1 47:30 am – 8:30 am Morning Coffee

8:30 am – 8:45 am Chairperson’s Welcome and Review of Day One


8:45 am – 9:45 am PANel DISCUSSION:

Partnering to Drive Down Health Care Costs by Achieving Appropriate Utilization of Treatment Services • Discuss how to achieve the balance between the growth in drug spending and premium costs with access, cost-sharing, and clinical value• Identify opportunities to improve adherence and persistency in the specialty pharmacy setting• Address the need to expand and streamline pharma access programs to make them accessible, helpful, easy-to-use destinations• Examine a new emerging venture philanthropy model that spurs drug development for orphan and specialty diseases

Moderator:


Panelists:

todd Hudson Senior Director, Market Access nPS PHARMA

leslie S. Fish, Pharmd Vice President, Clinical Programs FAllon CoMMunity HeAltH PlAn

Pat Furlong Founding President, Chief Executive Officer PARent PRoJeCt MuSCulAR dyStRoPHy

Raymond R. Rede Vice President, Managed Care Relations CoMMunity SPeCiAlty PHARMACy netWoRK

eric R. toppy Global Launch Leader, INVOKANA – Global Commercial Strategic Organization JoHnSon & JoHnSon

9:45 am – 10:30 am evaluate the Impact of the Health Insurance exchange Plans on Patient Access to Specialty Drugs

• Discuss benefit design strategies in play for specialty drug benefits for participants on Exchange plans• Share ways to improve transparency and information on what drugs will be covered in the health plan

Kevin g. Cast Vice President, Global Pharmaceutical Business Development uBC

Mr. Cast joined the Express Scripts management team in February 2003. In his role, Mr. Cast oversees contracting for specialty pharmaceuticals and the sale of ancillary services that support pharmaceutical manufacturer products. Mr. Cast leads the Business Development team, which is focused on the UBC offerings of Express Scripts, including pharmacovigilance, risk mitigation, specialty pharmacy, specialty distribution, third party logistics, REMS, reimbursement, PAP, custom adherence programs, data and sales reporting, consulting, and nursing networks.

10:30 am – 11:00 am Networking and Refreshment Break


d a y t W o – t u e S d a y , J u l y 2 9 , 2 0 1 4 ( c o n t i n u e d ) S P o t l i G h t o n t e c h n o l o G i e S

11:00 am – 11:45 am Amplify the High-Touch of Specialty Pharmacy through Mobile and Web-Based Tools

• Examine the shift toward digital — Evolving customer demands and engagement opportunities • Delve into a an Avella Specialty Pharmacy case study highlighting mobile and web-based tools • Identify industry best practices and early adopter examples

Rebecca Shanahan, esq Chief Executive Officer AvellA SPeCiAlty PHARMACy

11:45 am – 12:30 pm Improve engagement and Adherence 24/7 by Utilizing Virtual Health Assistants in a Specialty Pharmacy

• Outline the ways a VHA can improve the chronic disease management process in a specialty or retail pharmacy in addition to a pharmaceutical company

• Discuss real-life applications of VHA in healthcare and other industries• Impact of a VHA on health outcomes and costs

thomas Morrow, Md Author of “Tomorrow’s Medicine”

Author of “Tomorrow’s Medicine”, the longest running health care technology column printed in the US, Dr. Morrow has been the founding medical director for five HMOs, a clinical lead for a national disease management company and an NCQA surveyor. He currently works for a large bio-pharma company.

12:30 pm – 1:30 pm Luncheon

S P o t l i G h t o n a l t e r n a t i V e c h a n n e l M o D e l S1:30 pm – 2:15 pm Mitigate the Challenges of Working with Oncology Practice-Owned Specialty Pharmacies

• Weigh the pros and cons of an integrated approach that incorporates retail pharmacies within community oncology practices• Compare oncology practice owned pharmacies to retail chain pharmacies in terms of dedicated patient advocates, cost-sharing, prior

authorizations, reimbursement, and tracking • Demonstrate improved patient care, adherence rates, and patient and physician satisfaction as the industry shifts from IV to oral oncolytics• Discuss a patient service partnership model that offers a portfolio of flexible offerings and that ensures consistency of patient services for all channels

of sites of cancer treatment delivery — including a network of geographically dispersed practices

Kelly Burgeson Executive Director, Oncology Pricing, Access, Reimbursement and Distribution, BoeHRingeR-ingelHeiM

Jeffrey Patton, Md Chief Executive Officer tenneSSee onCology, PllC

2:15 pm – 3:00 pm Health System-Based Specialty Pharmacies to Drive Prescribing and Appropriate Use at the

Point-of-Care • Discuss the trend of hospital system expansion into specialty pharmacy offerings• Understand how the EHR can be leveraged to better coordinate specialty medication management• The critical role of specialty medication management in an ACO

Kevin Colgan, MA, FASHP Corporate Director of Pharmacy RuSH univeRSity MediCAl CenteR

Michael deCoske, Pharmd, BCPS Associate Chief Pharmacy Officer duKe univeRSity HoSPitAl

3:00 pm Close of Summit

W H Y YO U S H O U L D

S P O N S O R

POSITION your company as a leading

solutions and service provider

MEET your market

SHOWCASE new technology

innovations

INCREASE brand awareness

GENERATE leads and new

business

DEVELOP new and

current client relationships

To inquire about Sponsorship and Executive Networking Opportunities, Contact David Capobianco, Vice President, Business Development, World Congress Call 781-939-2635 or email [email protected]

RegistRation Fee: Register By6/13/2014

Register By7/28/2014standaRd

Conference $ 2595.00 $ 2795.00Conference Plus 1 Workshop $ 2895.00 $ 3095.00PhaRma / BioteChConference $ 1795.00 $ 1995.00

Conference Plus 1 Workshop $ 2095.00 $ 2295.00

Fee for conference includes welcome coffee, lunch, reception, refreshments, and web-based conference documentation available pre- and post-event, accessible through password-protected website. Checks in U.S. funds drawn from U.S. bank payable to: WC Research Inc. No personal checks accepted. Verification may be required for rate approvals. Please contact us should you have any special needs.

sPeCiaL teaM DisCoUnts: With so much great content, you can’t possibly cover it alone. Sign up your team and save. Find out more about special group package discounts by calling 800-767-9499 or emailing [email protected].

PaRtiCiPant sUbstitUtion anD CanCeLLations: Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. Cancellations received in writing on or before 30 days prior to the start of the event will be refunded, less a $395 administrative charge. No refunds will be made after this date; however, the registration fee less the $395 administrative charge can be credited to another World Congress conference if you register within 6 months from the date of this conference. In case of conference cancellation, World Congress’ liability is limited to refund of the conference registration fee only. World Congress reserves the right to alter this program without prior notice.

satisFaCtion gUaRanteeD: World Congress stands behind the quality of its conferences. If you are not satisfied with the quality of the conference, a credit will be awarded towards a comparable World Congress conference of your choice.

WeBSiteWorldCongress.com/ Specialty

RegisteR now! [email protected]

Best value

PRSRt Stdu.S. Postage

PAidgallery

World Congress500 West Cummings Park, Suite 5200Woburn, MA 01801PB14009

VenUe: Hyatt at the bellevue 200 south Broad street Philadelphia, Pa 19102 888-421-1442 philadelphia.bellevue.hyatt.com Room Rate: $169 Cut-off Date: 7/7/14

ATTN Mail Room: If undeliverable please forward to trade/channel/national account managers

S a v e u p t o $ 2 0 0 W h e n y o u r e g i S t e r B y J u n e 1 3 , 2 0 1 4 !

To register, please visit www.worldcongress.com/specialty Phone: 800-767-9499 • Fax: 781-939-2543

Email: [email protected]

f e a t u r e d S p e a K e r S i n c l u d e : Molly Burich

Senior Manager, Government Affairs – Reimbursement and Policy otSuKA PHARMACeutiCAlS

leslie S. Fish, Pharmd Vice President, Clinical Programs FAllon CoMMunity HeAltH PlAn

Bill goodson Deputy Director, Pricing, Reimbursement and Patient Assistance BAyeR HeAltHCARe

Jeffrey Patton, Md Chief Executive Officer tenneSSee onCology, PllC

lynn Pezzullo, RPh, CPeHR Director of Performance Measurement and Research, PHARMACy QuAlity AlliAnCe, inC.

Wesley Winn Vice President, Commercial Operations, Supply Chain and Market Access HyPeRion tHeRAPeutiCS

�

S t r a t e g i e S t o i m p r o v e p a t i e n t S e r v i c e S a n d a d h e r e n c e t h r o u g h c o n t r a c t i n g a n d d a t a a n a l y t i c S

t h e W o r l d c o n g r e S S S u m m i t o n

Specialty Market acceSS and channel OptiMizatiOn

J u l y 2 8 - 2 9 , 2 0 1 4 • H y a T T a T T H E B E l l E v u E • P H i l a d E l P H i a , P a

Patient

Manufacturer

PBM

SPecialty PharMacy

Whole- Saler

PHone800-767-9499781-939-2400 outside the U.S.

the world congress summit on specialty market access and channel optimization

Healthcare